MedTrace Logo

The Role of Peptide YY (PYY)Infusions in Inhibiting Food Intake.

NCT00259246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2009-01-21

No results posted yet for this study

Summary

The aim of the study is to compare fasting and postprandial PYY levels between overweight/obese and lean subjects during and after an infusion of saline, PYY1-36 or PYY3-36 and to evaluate the efects on appetite, energy intake and energy expenditure.

Conditions

Interventions

DRUG

Peptide YY infusion

Sponsors & Collaborators

  • EC-FP6 (contract number: LHM-CT-2003-503041)

    collaborator UNKNOWN

  • Aditech Pharma AB

    collaborator INDUSTRY

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Arne Astrup, Professor · Department of Human Nutrition, RVAU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Completion
2005-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00259246 on ClinicalTrials.gov